StockData

Seaport Therapeutics, Inc. (SPTX) stock

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.32+0.01 (+0.05%)

Close on Nov 19, 2026Market cap $980.68MP/E –Yield –

Seaport Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$22.68M–
Q2 FY2026Jun 30, 2026-$26.14M–
Q1 FY2026Mar 31, 2026-$20.17M–
Q3 FY2025Sep 30, 2025-$15.77M–
Q2 FY2025Jun 30, 2025-$15.59M–
Q1 FY2025Mar 31, 2025-$20.26M–

More Seaport Therapeutics figures

See a number that looks wrong?